Innovative therapeutics

Investors

BioMarin Promotes Amy Wireman to Group Vice President, Human Resources
Dec 3, 2018

SAN RAFAEL, Calif., Dec. 3, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the promotion of Amy Wireman to Group Vice President, Human Resources.  Ms. Wireman's promotion to lead the Human Resources function globally is effective on January 1, 2019.   

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

"We are thrilled to promote Amy into the leadership role for Human Resources at BioMarin.  Our people are our greatest asset, and in a fast growing organization like BioMarin, an agile human resources function is essential to attracting, engaging and retaining top talent," said Jean-Jacques Bienaimé, Chairman and Chief Executive Officer.  "Amy has been integral in leading our efforts to enhance our total compensation packages around the world demonstrating our commitment to and appreciation for the people who work at BioMarin."

In this new leadership role, Ms. Wireman's responsibilities will include the HR Business Partners, the regional HR teams, learning and development, talent acquisition, compensation and benefits, HR systems and operations. Ms Wireman joined BioMarin in 2013 and has held roles of increasing responsibilities, starting with head of compensation and benefits, followed by responsibilities for HR operations, and most recently talent acquisition.  Ms. Wireman will be replacing Rich Ranieri, Head of Human Resources, who announced in June that he will be retiring from the company at the end of the year.

"I have worked closely with Amy and have the utmost respect for her HR talents, as well as her focus to creatively look for ways to develop employee programs to meet the needs of a growing workforce. She is uniquely qualified to help drive BioMarin's growth and will be a true champion for all of our employees around the globe," said Ranieri.

"I would like to thank Rich for his service and dedication to the employees of BioMarin.  He created a foundation within our organization that allows the company to scale its human resource function for rapid growth, and he developed a strong team of leaders to continue our important work," Bienaimé added.

Ms. Wireman previously held managerial HR positions at Wind River, Xyratex and Micromuse as well as senior consulting roles with Watson Wyatt and Mercer. Ms. Wireman is a graduate of New York University where she earned degrees in mathematics and Spanish. 

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases.  The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit www.biomarin.com.  Information on such website is not incorporated by reference into this press release.

Contacts:




Investors

Media

Traci McCarty 

Debra Charlesworth

BioMarin Pharmaceutical Inc. 

BioMarin Pharmaceutical Inc.

(415) 455-7558  

(415) 455-7451

 

SOURCE BioMarin Pharmaceutical Inc.


BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information